Given the availability of these bs-Abs and the fact that they can successfully target various receptors and signaling pathways, similar strategies could be employed to develop bs-Abs that effectively target TNFR2, Mb-TNF-α, and their associated receptor signaling pathways in BC. This evidence concerns the gene TNF and breast cancer.